CIPM 2025 Qingdao Recap | HUANGHAI Highlights in ODF & QC

1) Why CIPM Matters

The China International Pharmaceutical Machinery Exposition (CIPM) is one of the most influential platforms for pharma equipment in China, organized by the China Association for Pharmaceutical Equipment and held twice a year. The Autumn 2025 edition took place on 16–18 October at the Qingdao Cosmopolitan Exposition. With over 150,000 m² of show floor and more than 1,600 exhibitors across thematic halls—formulation equipment, API equipment, packaging, quality testing, cleaning systems, automation, and smart factory—CIPM is a key window for discovering new technologies, regulatory trends, and automation innovations.

2) Our Booth Highlights

At CIPM 2025 (Qingdao), HUANGHAI showcased three core technology tracks that drew strong interest from domestic and international visitors:

2.1 ODF Integrated Solution

We presented a full workflow from solution preparation → precision coating → drying → cutting & packaging → testing, demonstrating configurations that scale from R&D to commercial production. Visitors focused most on film thickness uniformity, drying efficiency, batch record retention, and ease of cleaning. Our engineers also explained how to mix and match modules for different dosage formats.

• Featured equipment: MJF180 ODF Film Cutting & Packaging
• Featured equipment: MJ150 ODF & Transdermal Patch Film Making Machine

2.2 Laser Drilling for Osmotic Tablets

We introduced the Olando K3-2 system with the vision module, highlighting an integrated approach of stable orifice control + auto rejection + data traceability. Multiple formulators asked how to connect the laser module to MES/LIMS to meet FDA 21 CFR Part 11 audit trails.

• Product page: Olando K3-2 Pharmaceutical Laser Drilling System
• Key points: in-line vision inspection, auto-reject, nonconformity statistics, batch record retention.

2.3 QC & Lab Instruments

We displayed core instruments including dissolution testers, disintegration testers, tablet hardness testers, and moisture analyzers, with live demonstrations of printer/PC connectivity to streamline data capture and analysis for GMP workflows.

• Explore more: Dissolution Instruments collection
• Use cases: formulation screening, process optimization, release testing, stability studies, incoming and in-process checks.

3) In the Field

Throughout the show, our team engaged with visitors from India, Vietnam, Canada, Egypt, and across China. Many tried our instruments on site and expressed interest in product trials or co-development. ODF patches, oral dissolvable films, and functional nutrition applications were frequent topics—signaling strong market momentum for thin-film formats.

4) Compliance & Future Outlook

In response to increasingly rigorous global regulations, we continue to strengthen:

• Data integrity & electronic signatures (21 CFR Part 11 ready)
• GMP validation documentation support (DQ / IQ / OQ / PQ)
• Modular expansion interfaces and custom automation retrofits

Looking ahead, HUANGHAI will focus on high-precision coating, smart inspection, and data compliance to support pharma and health-product manufacturing at higher standards.

5) Join Us

Thank you to everyone who visited our booth at CIPM 2025 Qingdao. If you missed the live demos, we welcome you to:

• Book an online demonstration or send samples for feasibility runs
• Request our ODF & QC solution briefs
• Discuss quotations or technical proposals

👉 Contact HUANGHAI

---

*Images are from the exhibition. For media use or originals, please contact us. Specifications are subject to the final technical agreement and quotation.

*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.

*Designed to meet Class I Div 1 / ATEX explosion-proof standards for safe transdermal solvent handling.

---

Frequently Asked Questions

Q: What is the difference between an ODF film and a transdermal patch?

A: Oral Dissolving Films (ODF) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar solvent-cast film coating processes. Huanghai's MJ150 ODF machine supports both applications on a single platform with approximately 2 working days of changeover time.

Q: What production output can I expect from a Huanghai ODF machine?

A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either machine with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.

Q: What drying technology does Huanghai use for ODF production?

A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform film thickness, reduced edge curl, and better API distribution across the film web. An optional far-infrared heating module adds 20–30% drying efficiency for solvent-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ODF equipment supplier to Sinopharm, Shanghai Pharma, and Fosun Pharma.

Q: What are the GMP requirements for ODF production equipment?

A: ODF manufacturing equipment must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent standards (EU GMP Annex 1, ChGMP) for other markets. Key requirements: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; data integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ODF machines meet these standards—all product contact surfaces use pharmaceutical-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP compliance documentation.

Q: Can Huanghai machines produce stripe-coated or multi-formula ODF films?

A: Yes. Huanghai holds a patent for multi-formula stripe coating (Patent CN117323228A), enabling two different API formulations to be applied side-by-side in a single coating pass. This eliminates the need for multiple coating/drying cycles when producing combination-drug ODF products. Competitors require manual multi-layer coating with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-API ODFs for cardiovascular or CNS indications) where coating efficiency directly impacts production economics.